Nestlé is to develop so-called ‘functional foods’, which are designed to prevent and treat diseases including obesity and diabetes, but are not registered as pharmaceuticals.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.